262 related articles for article (PubMed ID: 26090570)
1. Myotonic dystrophy kinase-related Cdc42-binding kinases (MRCK), the ROCK-like effectors of Cdc42 and Rac1.
Zhao Z; Manser E
Small GTPases; 2015; 6(2):81-8. PubMed ID: 26090570
[TBL] [Abstract][Full Text] [Related]
2. Cdc42-MRCK and Rho-ROCK signalling cooperate in myosin phosphorylation and cell invasion.
Wilkinson S; Paterson HF; Marshall CJ
Nat Cell Biol; 2005 Mar; 7(3):255-61. PubMed ID: 15723050
[TBL] [Abstract][Full Text] [Related]
3. Myotonic dystrophy kinase-related Cdc42-binding kinase acts as a Cdc42 effector in promoting cytoskeletal reorganization.
Leung T; Chen XQ; Tan I; Manser E; Lim L
Mol Cell Biol; 1998 Jan; 18(1):130-40. PubMed ID: 9418861
[TBL] [Abstract][Full Text] [Related]
4. Adaptor protein LRAP25 mediates myotonic dystrophy kinase-related Cdc42-binding kinase (MRCK) regulation of LIMK1 protein in lamellipodial F-actin dynamics.
Lee ICJ; Leung T; Tan I
J Biol Chem; 2014 Sep; 289(39):26989-27003. PubMed ID: 25107909
[TBL] [Abstract][Full Text] [Related]
5. Opportunities and Challenges for the Development of MRCK Kinases Inhibitors as Potential Cancer Chemotherapeutics.
Ruscetta VM; Seaton TJ; Shakeel A; Vasconcelos SNS; Viirre RD; Adler MJ; Olson MF
Cells; 2023 Feb; 12(4):. PubMed ID: 36831201
[TBL] [Abstract][Full Text] [Related]
6. Cdc42 antagonizes inductive action of cAMP on cell shape, via effects of the myotonic dystrophy kinase-related Cdc42-binding kinase (MRCK) on myosin light chain phosphorylation.
Dong JM; Leung T; Manser E; Lim L
Eur J Cell Biol; 2002 Apr; 81(4):231-42. PubMed ID: 12018391
[TBL] [Abstract][Full Text] [Related]
7. Intermolecular and intramolecular interactions regulate catalytic activity of myotonic dystrophy kinase-related Cdc42-binding kinase alpha.
Tan I; Seow KT; Lim L; Leung T
Mol Cell Biol; 2001 Apr; 21(8):2767-78. PubMed ID: 11283256
[TBL] [Abstract][Full Text] [Related]
8. A novel small-molecule MRCK inhibitor blocks cancer cell invasion.
Unbekandt M; Croft DR; Crighton D; Mezna M; McArthur D; McConnell P; Schüttelkopf AW; Belshaw S; Pannifer A; Sime M; Bower J; Drysdale M; Olson MF
Cell Commun Signal; 2014 Oct; 12():54. PubMed ID: 25288205
[TBL] [Abstract][Full Text] [Related]
9. Rap1 potentiates endothelial cell junctions by spatially controlling myosin II activity and actin organization.
Ando K; Fukuhara S; Moriya T; Obara Y; Nakahata N; Mochizuki N
J Cell Biol; 2013 Sep; 202(6):901-16. PubMed ID: 24019534
[TBL] [Abstract][Full Text] [Related]
10. The myotonic dystrophy kinase-related Cdc42-binding kinase is involved in the regulation of neurite outgrowth in PC12 cells.
Chen XQ; Tan I; Leung T; Lim L
J Biol Chem; 1999 Jul; 274(28):19901-5. PubMed ID: 10391936
[TBL] [Abstract][Full Text] [Related]
11. Characterization of the interaction of phorbol esters with the C1 domain of MRCK (myotonic dystrophy kinase-related Cdc42 binding kinase) alpha/beta.
Choi SH; Czifra G; Kedei N; Lewin NE; Lazar J; Pu Y; Marquez VE; Blumberg PM
J Biol Chem; 2008 Apr; 283(16):10543-9. PubMed ID: 18263588
[TBL] [Abstract][Full Text] [Related]
12. Structure and regulation of the myotonic dystrophy kinase-related Cdc42-binding kinase.
Truebestein L; Antonioli S; Waltenberger E; Gehin C; Gavin AC; Leonard TA
Structure; 2023 Apr; 31(4):435-446.e4. PubMed ID: 36854301
[TBL] [Abstract][Full Text] [Related]
13. Zhuidu Formula suppresses the migratory and invasive properties of triple-negative breast cancer cells via dual signaling pathways of RhoA/ROCK and CDC42/MRCK.
Wu Q; Ma X; Jin Z; Ni R; Pan Y; Yang G
J Ethnopharmacol; 2023 Oct; 315():116644. PubMed ID: 37196814
[TBL] [Abstract][Full Text] [Related]
14. The CDC42 effector protein MRCKβ autophosphorylates on Threonine 1108.
Unbekandt M; Lilla S; Zanivan S; Olson MF
Small GTPases; 2020 Nov; 11(6):451-460. PubMed ID: 30667325
[TBL] [Abstract][Full Text] [Related]
15. Myosin II regulation during C. elegans embryonic elongation: LET-502/ROCK, MRCK-1 and PAK-1, three kinases with different roles.
Gally C; Wissler F; Zahreddine H; Quintin S; Landmann F; Labouesse M
Development; 2009 Sep; 136(18):3109-19. PubMed ID: 19675126
[TBL] [Abstract][Full Text] [Related]
16. Advances in the studies of roles of Rho/Rho-kinase in diseases and the development of its inhibitors.
Guan R; Xu X; Chen M; Hu H; Ge H; Wen S; Zhou S; Pi R
Eur J Med Chem; 2013; 70():613-22. PubMed ID: 24211637
[TBL] [Abstract][Full Text] [Related]
17. RhoE stimulates neurite-like outgrowth in PC12 cells through inhibition of the RhoA/ROCK-I signalling.
Talens-Visconti R; Peris B; Guerri C; Guasch RM
J Neurochem; 2010 Feb; 112(4):1074-87. PubMed ID: 19968760
[TBL] [Abstract][Full Text] [Related]
18. Discovery of Potent and Selective MRCK Inhibitors with Therapeutic Effect on Skin Cancer.
Unbekandt M; Belshaw S; Bower J; Clarke M; Cordes J; Crighton D; Croft DR; Drysdale MJ; Garnett MJ; Gill K; Gray C; Greenhalgh DA; Hall JAM; Konczal J; Lilla S; McArthur D; McConnell P; McDonald L; McGarry L; McKinnon H; McMenemy C; Mezna M; Morrice NA; Munro J; Naylor G; Rath N; Schüttelkopf AW; Sime M; Olson MF
Cancer Res; 2018 Apr; 78(8):2096-2114. PubMed ID: 29382705
[TBL] [Abstract][Full Text] [Related]
19. An apical MRCK-driven morphogenetic pathway controls epithelial polarity.
Zihni C; Vlassaks E; Terry S; Carlton J; Leung TKC; Olson M; Pichaud F; Balda MS; Matter K
Nat Cell Biol; 2017 Sep; 19(9):1049-1060. PubMed ID: 28825699
[TBL] [Abstract][Full Text] [Related]
20. The actin-myosin regulatory MRCK kinases: regulation, biological functions and associations with human cancer.
Unbekandt M; Olson MF
J Mol Med (Berl); 2014 Mar; 92(3):217-25. PubMed ID: 24553779
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
